AYTU BIOPHARMA, INC (AYTU)

2.25 +0.45% (+0.01)

Over 1Y: -2.6%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 2.5
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q4 '21 — Revenue: 23.5M Q4 '21 — Operating Cash Flow: -6.3M Q4 '21 — Net Income: -19M Q1 '22 — Revenue: 21.9M Q1 '22 — Operating Cash Flow: -3.8M Q1 '22 — Net Income: -27.9M Q2 '22 — Revenue: 23.1M Q2 '22 — Operating Cash Flow: -8.8M Q2 '22 — Net Income: -11.5M Q3 '22 — Revenue: 24.2M Q3 '22 — Operating Cash Flow: -9.1M Q3 '22 — Net Income: -53.3M Q4 '22 — Revenue: 27.4M Q4 '22 — Operating Cash Flow: -7.1M Q4 '22 — Net Income: -16.1M Q1 '23 — Revenue: 27.7M Q1 '23 — Operating Cash Flow: -9.1M Q1 '23 — Net Income: -701K Q2 '23 — Revenue: 26.3M Q2 '23 — Operating Cash Flow: -2.4M Q2 '23 — Net Income: -6.7M Q3 '23 — Revenue: 22.7M Q3 '23 — Operating Cash Flow: -2.9M Q3 '23 — Net Income: -7.2M Q4 '23 — Revenue: 30.7M Q4 '23 — Operating Cash Flow: 9.4M Q4 '23 — Net Income: -2.5M Q1 '24 — Revenue: 17.8M Q1 '24 — Operating Cash Flow: -211K Q1 '24 — Net Income: -8.1M Q2 '24 — Revenue: 18.7M Q2 '24 — Operating Cash Flow: -135K Q2 '24 — Net Income: -220K Q3 '24 — Revenue: 14M Q3 '24 — Operating Cash Flow: -254K Q3 '24 — Free Cash Flow: -254K Q3 '24 — Net Income: -2.9M Q4 '24 — Revenue: 14.6M Q4 '24 — Operating Cash Flow: -788K Q4 '24 — Net Income: -4.6M Q1 '25 — Revenue: 16.6M Q1 '25 — Operating Cash Flow: -1.2M Q1 '25 — Free Cash Flow: -1.3M Q1 '25 — Net Income: 1.5M Q2 '25 — Revenue: 16.2M Q2 '25 — Operating Cash Flow: 2.9M Q2 '25 — Free Cash Flow: 2.9M Q2 '25 — Net Income: 788K Q3 '25 — Revenue: 18.5M Q3 '25 — Operating Cash Flow: -6.5M Q3 '25 — Free Cash Flow: -6.5M Q3 '25 — Net Income: 4M Q4 '25 — Revenue: 15.1M Q4 '25 — Operating Cash Flow: 2.8M Q4 '25 — Free Cash Flow: 2.8M Q4 '25 — Net Income: -19.8M Q1 '26 — Revenue: 13.9M Q1 '26 — Operating Cash Flow: -618K Q1 '26 — Free Cash Flow: -618K Q1 '26 — Net Income: 2M Q2 '26 — Revenue: 15.2M Q2 '26 — Operating Cash Flow: 3.7M Q2 '26 — Free Cash Flow: 3.7M Q2 '26 — Net Income: -10.6M Q3 '26 — Revenue: 12.4M Q3 '26 — Operating Cash Flow: -4.2M Q3 '26 — Free Cash Flow: -4.2M Q3 '26 — Net Income: -5.6M -40M -20M 0 20M 40M
Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-03-31, reported in USD. The newest fact in the filings is dated 2026-03-31, 152 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.5
OE margin 1.7%
Oper. margin -26.8%
ROIC -60.4%
Accruals -32.0%
Gross margin 64.8%
EBITDA margin -19.2%
FCF margin 2.9%
OCF margin 3.0%
Profit margin -60.2%
ROA -30.5%
ROCE -29.3%
ROE -96.9%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.7
ND/EBITDA —
Cash / Debt 2.3×
Debt payback 0.0 yr
Debt / Eq 0.32×
F-score 4.0 pts
Cash runway —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.1
Sales CAGR 4Y +0.28%
Sales/sh Y/Y -24.2%
EPS Y/Y -1932.2%
Sales Q/Q -32.7%
Shares change +13.4%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.